Diagnostic and prognostic testing to evaluate coronary artery disease in patients with diabetes mellitus
Diagnostic and prognostic testing to evaluate coronary artery disease in patients with diabetes mellitus
复制标题
DOI：
10.1007/s11154-010-9129-1
复制
发表时间：
2010-03
影响因子：
8.2
通讯作者：
Neal B. Patel;G. Balady
中科院分区：
文献类型：
--
作者：
Neal B. Patel;G. Balady
冠状动脉疾病（CAD）仍然是糖尿病（DM）患者发病和死亡的最常见原因。近年来，糖尿病合并冠心病的治疗策略发生了很大的变化。目前，所有糖尿病患者，无论症状或诊断CAD，积极治疗CAD风险因素减少。在这种临床环境下，特异性识别将受益于更积极和侵入性治疗的疾病患者的能力仍然是一个挑战。在这篇文章中，我们回顾了目前的文献中的诊断和预后效用的传统非侵入性方式评估糖尿病患者的CAD，以及新的和新兴的方法CAD风险分层。
Coronary artery disease (CAD) continues to be the most common cause of morbidity and mortality in patients with diabetes mellitus (DM). In recent years, the strategies for treatment of CAD in DM have undergone much evolution. Currently, all patients with DM, regardless of symptoms or diagnosed CAD, are treated aggressively for CAD risk factor reduction. In this clinical climate, the ability to specifically identify patients with disease that will benefit from more aggressive and invasive therapies remains a challenge. In this article we review the current literature on diagnostic and prognostic utility of conventional non-invasive modalities for assessment of CAD in patients with DM, as well as on novel and emerging methods for CAD risk stratification.